Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Jury Deliberations Continue in First Trial of Fosamax Litigation September 9, 2009 AboutLawsuits Add Your Comments Although jurors have indicated that they will not be able to reach an agreement in the first Fosamax trial over whether a 71 year old woman woman suffered debilitating jaw necrosis as a side effect of the osteoporosis drug, U.S. District Judge John Keenan has ordered them to continue deliberations in hopes of reaching a verdict. The case is one of nearly 1,000 Fosamax lawsuits pending against Merck & Co. with similar allegations that the drug can cause decay or “death” of the jaw bone. It is the first of three scheduled “bellwether” trials, which were selected for early trials to gauge the jury’s response to issues that will be common to many cases throughout the Fosamax litigation. Following the first nine hours of deliberations after closing arguments concluded on September 2, several notes were sent to the judge stating that at least some jurors believe an agreement cannot be reached. According to a report by Bloomberg News, the jurors met for a few more hours yesterday after being told to continue working, and they are scheduled to resume deliberations today. Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The jury got the case after a three-week trial in the U.S. District Court for the Southern District of New York in Manhattan. The case involves allegations by Shirley Boles, who says that she developed severe jaw damage after using Fosamax between 1997 and 2006. The condition, known as osteonecrosis of the jaw or ONJ, involves irreversible decay of the jawbone, which is painful and potentially disfiguring. It is associated with jaw infection and portions of the jawbone becoming exposed inside the mouth, potentially requiring surgery to remove parts of the jaw. Lawsuits against Merck allege that Fosamax side effects increase the risk of ONJ when the drug is taken over long periods of time, and claim that the drug maker failed to adequately research their popular product or warn about the risk. Fosamax (alendronate sodium) was approved by FDA in October 1995, and has been used by more than 20 million people. Before the medication became available as a generic last year, Fosamax sales generated more than $3 billion annually for Merck. The company faces more than 900 state and federal lawsuits over the ONJ claims. According to the initial scheduling order, the Boles case will be followed by a second Fosamax bellwether trial on December 1, 2009 and a third scheduled to begin January 11, 2010. Tags: Alendronate, Alendronate Sodium, Fosamax, Jaw Necrosis, Merck, ONJ, Osteonecrosis of the Jaw Image Credit: | More Fosamax Lawsuit Stories Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022 Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study January 14, 2021 Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: today) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025) First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: today) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025) Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: yesterday) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)
Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020
Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (Posted: today) A hairdresser who has worked for nearly 40 years in the industry says her constant exposure to hair dye led to a bladder cancer diagnosis. MORE ABOUT: HAIR DYE LAWSUITSalon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)Hair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)
First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (Posted: today) An Oxbryta class action lawsuit has been scheduled for trial in August 2027, but must first survive a motion to dismiss filed by manufacturers. MORE ABOUT: OXBRYTA LAWSUITMalpractice Lawsuit Alleges Side Effects of Oxbryta Caused Untimely Death (04/15/2025)At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics (03/14/2025)After Recalling Oxbryta, Pfizer Seeks Dismissal of Class Action Brought by Former Users (03/07/2025)
Court Urged To Combine 5 AFFF Lawsuits For First MDL Bellwether Trial (Posted: yesterday) Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL. MORE ABOUT: AFFF LAWSUITAdditional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (04/29/2025)Firefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)